Stock · BBIO · Drug & medical companies
Members of Congress trading BridgeBio Pharma, Inc. (BBIO)
1 member of Congress reported 8 trades in BridgeBio Pharma, Inc. (BBIO) since January 2025: 7 purchases and 1 sale, worth $8,008 to $120K in total. Rep. Gilbert Ray Cisneros, Jr. traded it most, 8 times. The latest reported trade was on Sep 29, 2026.
- Members who traded it
- 1
- Trades since 2025
- 8
- Purchases
- 7
- Sales
- 1
- Reported value
- $8,008–$120K
- Democrats / Republicans
- 1 / 0
Who in Congress trades it
- Rep. Gilbert Ray Cisneros, Jr. D-CA-318 trades
Latest trades
- Rep. Gilbert Ray Cisneros, Jr. soldSep 29, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtMay 11, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtApr 29, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtMar 19, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtMar 18, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtMar 3, 2026 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtSep 22, 2025 · $1,001–$15K
- Rep. Gilbert Ray Cisneros, Jr. boughtAug 8, 2025 · $1,001–$15K
About these numbers
Members of Congress must report stock trades by themselves, their spouses and dependent children within 45 days, in dollar ranges rather than exact amounts. Trading stock is legal. This page lists trades reported on House and Senate periodic transaction reports since January 1, 2025, as of Oct 17, 2026.
Related
From House Clerk and Senate disclosure reports. Each member’s profile links to the original filings.
Cite or embed this page
Capitol Receipts, “BridgeBio Pharma (BBIO) Stock Trades by Members of Congress,” https://www.capitolreceipts.com/stock/BBIO/bridgebio-pharma-inc (accessed 2026-10-17).